Newsroom

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les maladies cérébrales et périphériques impliquant le récepteur CB1, annonce aujourd’hui, à l’occasion de la Journée mondiale de la trisomie 21, le lancement réussi de son étude clinique de Phase 2B avec AEF0217 pour le traitement des troubles comportementaux et cognitifs a...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain and peripheral diseases involving the CB1 receptor, announces today, on World Down Syndrome Day, the successful launch of its Phase 2B clinical trial with AEF0217 for the treatment of the behavioral and cognitive impairments associated with Down syndrome (Trisomy 21), with recruitment now underway...

東京--(BUSINESS WIRE)--(美國商業資訊)-- Kao Corporation旗下防曬品牌Bioré UV於近日舉辦了「YOUR ONE AND ONLY. Biore全球品牌活動」，以慶祝其全球宣傳活動「SUNLIGHT IS YOUR SPOTLIGHT.」的啟動。該活動特邀世界知名男團Stray Kids出席典禮。活動中，全體八位成員登台亮相，首次公開了與Bioré UV合作的音樂作品——歌曲《Endless Sun》的主題影片，並參與了座談會，分享了創作過程中的獨家故事。 專題網站：https://www.kao.co.jp/bioreuv/sunlightisyourspotlight/en/ 全球擴張與韓國市場策略 在活動開場時，Kao公布了旗下產品目前已行銷66個國家與地區的Bioré UV的全球戰略，以及全面進軍韓國市場的計畫。Kao護膚事業部(Bioré)副總裁Emi Kobayashi在演講中闡述了公司的宏偉願景：「韓國是Bioré全球策略中最重要的樞紐之一。我們相信，進軍護膚理念高度成熟的韓國市場，是Bioré持續進化為真正全球化品牌的重要一步。」...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will host an industry session at the 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on March 22, 2026, from 2:30pm - 4pm CET in Madrid, Spain. The session, titled “Advances in TA-TMA Treatment: Evaluating the Role of a Novel Targeted Therapy,” will be co-chaired by Rafael Duarte, MD, PhD, Hospital Universitario Puerta de Hierro Majadahonda, and Mohamad Mohty, MD, PhD, Hôp...

LOS ANGELES--(BUSINESS WIRE)--PSIX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Power Solutions International, Inc....

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Fortinet Inc. (the “Company”) (NasdaqGS: FTNT). On August 6, 2025, the Company disclosed disappointing second-quarter 2025 financial results, including that it was already “approximately 40% to 50% of the way through the 2026 upgrade cycle at the end of the second quarter...

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Medeoprichter, voorzitter en CEO Robert Friedland, en medeoprichter en Chief Technology Officer Laurent Frescaline van I-Pulse – wereldwijd marktleider op het gebied van hoogenergetische pulsenergietechnologieën – kondigen met genoegen de overname van CSI Technologies, Inc. aan. Dit in Californië gevestigde bedrijf is een fabrikant van hoogenergetische hoogspanningscondensatoren voor industriële, medische en defensietoepassingen. Deze strategische overname ve...

SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting udbygger sine kompetencer inden for teknologi og risikostyring gennem en samarbejdsaftale med Trillium Information Security Systems (TISS), et cybersikkerhedsfirma. Med en tilstedeværelse i Canada og Pakistan leverer TISS omfattende cybersikkerhedsløsninger til organisationer inden for finans, telekommunikation og den offentlige sektor. Virksomhedens team tilbyder et bredt udvalg af ydelser, herunder sikkerhedsvurderinger, managed security ope...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until May 18, 2026 to file lead plaintiff applications in a securities class action lawsuit against Gartner, Inc. (NYSE: IT) (“Gartner” or the “Company”), if they purchased or otherwise acquired the Company’s shares between February 4, 2025, and February 2, 2026, inclusive (the “Class Peri...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Hercules Capital, Inc. (NYSE: HTGC) securities between May 1, 2025 and February 27, 2026. Hercules Capital is a private credit firm, also known a Business Development Company, which specializes in making private loans to companies. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Al...